✦ LIBER ✦

Long-term treatment with recombinant interferon alpha-2b prolongs survival of asymptomatic HIV-infected individuals

✍ Scribed by J. Rivero; M. Fraga; I. Cancio; J. Cuervo; P. López-Saura

Book ID: 110620767
Publisher: Springer
Year: 1997
Tongue: English
Weight: 490 KB
Volume: 10
Category: Article
ISSN: 0921-299X
DOI: 10.1007/bf02678537

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of long-term effects of lymph

Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B

✍ S.-M. Lin; D.-I. Tai; R.-N. Chien; I.-S. Sheen; C.-M. Chu; Y.-F. Liaw 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Treatment of chronic hepatitis C in HIV

Treatment of chronic hepatitis C in HIV infected patients (PTS) with pegylated interferon alpha 2B (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2B

✍ A. Cargnel; E. Angeli; A. Mainini; A. Casella; G. Gubertini; R. Giorgi; G. Orlan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Individualized treatment with combinatio

Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3

✍ Alessandra Mangia; Franco Bandiera; Giuseppe Montalto; Leonardo Mottola; Valeria 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 687 KB

Long-term results regarding the use of r

Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia

✍ Vito Michele Lauta; M. Antonietta De Sangro 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 659 KB

547 Mitochondrial effects of a 24-week c

547 Mitochondrial effects of a 24-week course of pegylated-interferon (PEG-IFN) plus ribavirin (RBV) in asymptomatic HCV/HIV CO-infected patients on long-term treatment with didanosine, stavudine or both

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l